Observational
Other(no intervention)
NCT Number: NCT05149859
* Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established. * Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity. * Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care.
The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Centre d'expertise Poids, Image et Alimentation (CEPIA), Québec, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Secondary exclusion criteria:
(no intervention)
Time frame: Inclusion
Number of current associated comorbidities to patient with and without BED
Time frame: Inclusion
To assess binge eating severity based on the 16-item scale developed by Gormally et al in 1982
Time frame: Inclusion
[Anthropometric markers] weight and height will be combined to report BMI in kg/m^2
Time frame: Inclusion
[Anthropometric markers] Based on impedance data, percentage fat mass will be reported when available
Time frame: Inclusion
[Anthropometric markers] Waist, hip circumference and Waist-hip ratio will be reported in cm when available
Time frame: Inclusion
Routine clinical biological markers; part of lipidic profile (when available)
Time frame: Inclusion
Routine clinical biological markers; part of lipidic profile (when available)
Time frame: Inclusion
Routine clinical biological markers, when available.
Time frame: Inclusion
Routine clinical biological markers, when available.
Time frame: Inclusion
Routine clinical biological markers, when available.
Time frame: Inclusion
The Visceral Adiposity Index (VAI) is a sex-specific mathematical index, based on Waist Circumference (WC), Body Mass Index (BMI), triglycerides (TG) and HDL cholesterol (HDL) levels, indirectly expressing visceral adipose function and insulin sensitivity.
Time frame: Inclusion
To assess the Impulsivity-compulsivity spectrum
Time frame: Inclusion
To assess the Impulsivity-compulsivity spectrum
Time frame: Inclusion
To assess the Impulsivity-compulsivity spectrum
Time frame: Inclusion
To assess the emotion regulation spectrum
Time frame: Inclusion
To assess the emotion regulation spectrum
Time frame: Inclusion
To assess attentional functions
Time frame: Inclusion
To assess attentional functions
Time frame: Inclusion
To assess anxiety disorders risk
Time frame: Inclusion
To assess depression disorder risk
Contact information is provided by the study sponsor or research team.
Pelletier Melissa
CONTACT
+1 (418) 656-8711 ext. 2136
Sylvain Iceta, MD, PhD
CONTACT
+1 (418) 656-8711 ext. 4565
Laval University
Other
Reconsidering Severity Classification for Binge Eating Disorder (BED): the Role of Impulsivity, Compulsivity and Co-occurring Disorders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07075952
Alzheimer Disease, Binge-Eating Disorder
Padova, Italy
View Trial DetailsNCT05693896
Binge Eating, Binge-Eating Disorder
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06848244
Binge Eating, Binge-Eating Disorder
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06864065
Behavior, Binge-Eating Disorder
Besançon, France
View Trial Details